Follow-up evaluations comprised
carcinoembryonic antigen (CEA) assay, physical examination and history, routine blood tests, and visualization every three months for the first two years, every six months from the third to the fifth year, and annually thereafter.
The serum level of tumor marker including
carcinoembryonic antigen and carbohydrate antigen 19-9 were 3.08 ng/mL and 0.6 U/mL, respectively.
Global
carcinoembryonic antigen market segmented based on application of
carcinoembryonic antigen: malignant condition and non-malignant condition.
Summary: Global
carcinoembryonic antigen market segmented based on application of
carcinoembryonic antigen: malignant condition and non-malignant condition.
Serum tumour marker
carcinoembryonic antigen (CEA) also plays an important role in diagnosis and prognosis of lung cancer.
Conclusion: Tumour depth, lymph node metastasis, postoperative
carcinoembryonic antigen levels, complete tumour response on histopathology were found to be responsible for metachronous liver metastases in rectal cancer patients following curative resection.
Immunohistochemical is favorable for antidiastole, especially prostate-specific antigen (PSA),
carcinoembryonic antigen, and
carcinoembryonic antigen 125.
Preoperative serum tumor markers, including
carcinoembryonic antigen, CA 125, CA 19-9, and, in one case, squamous cell carcinoma antigen, have been within normal limits.
C-stage in colon cancer: implications of
carcinoembryonic antigen biomarker in staging, prognosis, and management.
Anti-extractable nuclear antigen,
carcinoembryonic antigen, and alpha fetoprotein levels were unremarkable.
Perhaps the earliest markers to help in the clinical diagnosis were
carcinoembryonic antigen (CEA) in colon carcinomas11 and prostate specific antigen (PSA)12 in prostate cancer.